• Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.02
+0 (0.00%)

This chart shows the closing price for VLRXQ by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Valeritas Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VLRXQ and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VLRXQ

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Valeritas in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.02.

This chart shows the closing price for VLRXQ for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Valeritas. This rating has held steady since December 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/4/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/3/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/1/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/30/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/30/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/28/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/27/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/26/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/23/2019OppenheimerDowngradeOutperform ➝ Market Perform
12/23/2019BTIG ResearchDowngradeBuy ➝ Neutral
8/11/2019BTIG ResearchReiterated RatingBuy$14.00
7/9/2019OppenheimerBoost TargetOutperform$1.25 ➝ $12.00
5/10/2019OppenheimerSet TargetBuy$2.00
1/14/2019OppenheimerReiterated RatingBuy
12/4/2018BTIG ResearchInitiated CoverageBuy$1.00
11/21/2018OppenheimerSet TargetBuy$2.00
8/7/2018OppenheimerSet TargetBuy$4.00
7/5/2018CitigroupInitiated CoverageOutperform$3.50
7/5/2018OppenheimerInitiated CoverageOutperform$3.50
3/28/2018CowenDowngradeOutperform ➝ Market Perform
(Data available from 9/26/2017 forward)

News Sentiment Rating

0.52 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/28/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/30/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
4/29/2022
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/29/2022
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/28/2022
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/28/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/27/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/26/2022

Current Sentiment

  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Valeritas logo
Valeritas Holdings, Inc., a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States. The company offers V-Go, a wearable insulin delivery device for basal-bolus therapy. It also develops V-Go Prefill that is in the design-development stage for eliminating the device-filling process and the need for EZ fill refrigeration for patients with Type 2 diabetes; and V-Go SIM for real-time tracking information of basal and bolus dosing utilization. The company sells V-Go to third-party wholesalers and medical supply distributors. Valeritas Holdings, Inc. was founded in 2006 and is headquartered in Bridgewater, New Jersey.
Read More

Today's Range

Now: $0.02
Low: $0.02
High: $0.02

50 Day Range

MA: $0.02
Low: $0.02
High: $0.02

52 Week Range

Now: $0.02
Low: $0.01
High: $4.28

Volume

N/A

Average Volume

231,257 shs

Market Capitalization

$166.64 thousand

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Valeritas?

The following equities research analysts have issued research reports on Valeritas in the last twelve months:
View the latest analyst ratings for VLRXQ.

What is the current price target for Valeritas?

0 Wall Street analysts have set twelve-month price targets for Valeritas in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Valeritas in the next year.
View the latest price targets for VLRXQ.

What is the current consensus analyst rating for Valeritas?

Valeritas currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for VLRXQ.

What other companies compete with Valeritas?

How do I contact Valeritas' investor relations team?

Valeritas' physical mailing address is 750 ROUTE 202 SOUTH SUITE 600, BRIDGEWATER NJ, 08807. The company's listed phone number is 908-927-9920 and its investor relations email address is [email protected] The official website for Valeritas is www.valeritas.com. Learn More about contacing Valeritas investor relations.